Clinical Trial Update: Dexmedetomidine-based Sedation in Neurocritical Care Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating dexmedetomidine-based sedation in neurocritical care patients with acute brain injuries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Injury

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Acute Brain Injuries | Phase 2 | Status: UNKNOWN